Voluntary pause of the Phase 3 HERO and OLE trials evaluating ARD-101 for the treatment of hyperphagia in individuals with Prader-Willi Syndrome, ...
On the morning of this Sunday (22), national basketball fell silent to witness the departure of one of its most robust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results